21 March 2022

Experimental and in silico approaches to target selection and tractability for drug discovery

Organised by:

SCI's Fine Chemical's group and Society for Medicines Research (SMR)

Francis Crick Institute, London, UK

Register for this event

Registration Closed

This event is no longer available for registration.

Synopsis

A one day symposium jointly organised by the SCI’s Fine Chemicals Group and the Society for Medicines Research (SMR) on Monday 21 March 2022 at the Francis Crick Institute, London, UK.

The meeting will have two main themes:

  1. Sources of target hypotheses for drug discovery
  2. Practicalities of early assessment of target intervention opportunities

Speakers will include:

  • Lyn Jones (Dana-Farber Cancer Institute, Boston, USA)
  • Jessica Eley (GSK Stevenage, UK)
  • Victor Neduva (MSD, London, UK)
  • Deb Rothman, (Merck, USA)
  • Andrew Leach (EBI, Cambridge, UK)
  • Ian Storer (AstraZeneca, Cambridge, UK)
  • Paul Brennan (University of Oxford, UK)
    • Programme
    The programme can be found here.
    Venue

    SCI

    Francis Crick Institute
    1 Midland Road
    London, NW1 1AT

    Fees
    For more information about booking fees, please click here.

    Become an SCI Member and save on this and future events

    See Membership Options

    Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations